4.7 Article

Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes

Journal

DIABETES CARE
Volume 29, Issue 6, Pages 1395-1396

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc06-0494

Keywords

-

Funding

  1. NCRR NIH HHS [5U54 RR 014616] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available